Special report of the RSNA COVID-19 task force: systematic review of outcomes associated with COVID-19 neuroimaging findings in hospitalized patients
Open Access
- 29 April 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in The British Journal of Radiology
- Vol. 94 (1127), 20210149
- https://doi.org/10.1259/bjr.20210149
Abstract
Objective: We reviewed the literature to describe outcomes associated with abnormal neuroimaging findings among adult COVID-19 patients. Methods: We performed a systematic literature review using PubMed and Embase databases. We included all studies reporting abnormal neuroimaging findings among hospitalized patients with confirmed COVID-19 and outcomes. Data elements including patient demographics, neuroimaging findings, acuity of neurological symptoms and/or imaging findings relative to COVID-19 onset (acute, subacute, chronic), and patient outcomes were recorded and summarized. Results: After review of 775 unique articles, a total of 39 studies comprising 884 COVID-19 patients ≥ 18 years of age with abnormal neuroimaging findings and reported outcomes were included in our analysis. Ischemic stroke was the most common neuroimaging finding reported (49.3%, 436/884) among patients with mortality outcomes data. Patients with intracranial hemorrhage (ICH) had the highest all-cause mortality (49.7%, 71/143), followed by patients with imaging features consistent with leukoencephalopathy (38.5%, 5/13), and ischemic stroke (30%, 131/436). There was no mortality reported among COVID-19 patients with acute disseminated encephalomyelitis without necrosis (0%, 0/8) and leptomeningeal enhancement alone (0%, 0/12). Stroke was a common acute or subacute neuroimaging finding, while leukoencephalopathy was a common chronic finding. Conclusion: Among hospitalized COVID-19 patients with abnormal neuroimaging findings, those with ICH had the highest all-cause mortality; however, high mortality rates were also seen among COVID-19 patients with ischemic stroke in the acute/subacute period and leukoencephalopathy in the chronic period. Advances in knowledge: Specific abnormal neuroimaging findings may portend differential mortality outcomes, providing a potential prognostic marker for hospitalized COVID-19 patients.This publication has 131 references indexed in Scilit:
- Brain MRI Findings in Severe COVID-19: A Retrospective Observational StudyRadiology, 2020
- COVID-19–associated Diffuse Leukoencephalopathy and MicrohemorrhagesRadiology, 2020
- SARS-CoV-2 and Stroke in a New York Healthcare SystemStroke, 2020
- Neurovascular Complications in COVID-19 Infection: Case SeriesAmerican Journal of Neuroradiology, 2020
- Intracerebral haemorrhage and COVID-19: Clinical characteristics from a case seriesBrain, Behavior, and Immunity, 2020
- Stroke and mechanical thrombectomy in patients with COVID-19: technical observations and patient characteristicsJournal of NeuroInterventional Surgery, 2020
- Hemorrhagic Posterior Reversible Encephalopathy Syndrome as a Manifestation of COVID-19 InfectionAmerican Journal of Neuroradiology, 2020
- Stroke in patients with SARS-CoV-2 infection: case seriesZeitschrift für Neurologie, 2020
- COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcomeJournal of the Neurological Sciences, 2020
- Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: Case seriesBrain, Behavior, and Immunity, 2020